Literature DB >> 9078227

Third-generation oral contraceptives and venous thrombosis.

N R Poulter, C L Chang, M Marmot, T M Farley, O Meirik.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9078227     DOI： 10.1016/s0140-6736(05)60174-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  Benefits and risks of third-generation oral contraceptives.

Authors:  E S Leblanc; A Laws
Journal:  J Gen Intern Med       Date:  1999-10       Impact factor: 5.128

2.  Incidence of venous thromboembolism in users of combined oral contraceptives. Methods for identifying cases and estimating person time at risk must be detailed.

Authors:  H Jick
Journal:  BMJ       Date:  2000-01-01

Review 3.  Cardiovascular events associated with different combined oral contraceptives: a review of current data.

Authors:  P Hannaford
Journal:  Drug Saf       Date:  2000-05       Impact factor: 5.606

Review 4.  Choosing the best contraceptive method for the adult with congenital heart disease.

Authors:  Candice K Silversides; Mathew Sermer; Samuel C Siu
Journal:  Curr Cardiol Rep       Date:  2009-07       Impact factor: 2.931

5.  Validation of the diagnosis of venous thromboembolism in general practice database studies.

Authors:  R Lawrenson; J C Todd; G M Leydon; T J Williams; R D Farmer
Journal:  Br J Clin Pharmacol       Date:  2000-06       Impact factor: 4.335

Review 6.  Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms.

Authors:  I F Godsland; U Winkler; O Lidegaard; D Crook
Journal:  Drugs       Date:  2000-10       Impact factor: 9.546
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.